Onychomycosis Market is Increasing Rapidly at a CAGR of 7.9% During Forecast to 2023

 

Overview:

Onychomycosis or fungal infection is fast becoming a regular occurrence amongst the populace due to prevalent chronic disorders. It affects toenails or fingernails and, in the process, causes nail discoloration and increased thickness. The global onychomycosis market can expect an impressive CAGR of 7.9% during the forecast period (2017-2023), reveals Market Research Future (MRFR) in an extensively studied report. This market boom can be attributed to rising geriatric population, environmental condition, and prevalence of chronic diseases. Elderlies are susceptible to onychomycosis owing to their lessened immunity. Moist weather can also become a major decisive factor. Chronic disorders such as diabetes can also trigger its rapid spread. With rising demand for a cure, these factors can systematically boost the sale of drugs and affect market growth.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/8230

However, in developing regions,the low healthcare expenditure can become instrumental in choking the onychomycosis market during the forecast period. Also, a tendency can be witnessed among people of neglecting this disorder which can prove detrimental to the predicted growth.

Industry News:

A recent study, published in the Journal of Drugs in Dermatology, revealed that nanotechnology could be a possible answer for onychomycosis. Regular medications, if introduced as a blend with nanoparticles, become more effective in its curing process of the fungal infection. Nanoparticles also have a broad penetrative impact on nails which can prove beneficial for the treatment.

Iontophoresis is a device-based therapy that releases electrical currents to increase drug delivery. It creates microholes in the nails to improve the spreading of the medicines across the nail area. This technology is still awaiting clinical approval but is proving effective in its trials.  

Segmentation:

The global Onychomycosis Market Overview can be segmented by type, treatment, and end-user.

Type-wise segmentation includes distal subungual onychomycosis, white superficial onychomycosis, proximal subungual onychomycosis, candida onychomycosis and others.

Treatment-based segmentation includes drug treatment, tropical therapy, debridement and other.

Based on end-users, the market is segmented into hospital pharmacies, private pharmacies and other.

Regional Analysis:

Geographically, the onychomycosis market involves the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas dominate the market owing to the well-structured healthcare sector, awareness regarding the disease and tendency to spend much for a better life. A huge number of patients is also suffering from the disease which directly boosts the market.

Europe comes next. The region has a huge base for a geriatric population that triggers the market growth as they are more prone to diseases such as diabetes which can increase the chances of onychomycosis.

Access Full Report Details @ https://www.marketresearchfuture.com/reports/onychomycosis-market-1340

 

Meanwhile, the APAC is expected to register the fastest growth rate as developing economies in this region are spending more in healthcare and people are growing aware of such diseases and ready to shell out money for better treatment.

Competitive Dashboard:

The competitive market is eyeing for innovations and implementation of the latest technologies for a better outcome. To stay afloat,these companies are employing multiple strategies which can prove beneficial in the long run.

Key players profiled in the report as major market contributors are Polichem SA (Switzerland), Abbott Laboratories Ltd. (US), GlaxoSmithKline Plc. (UK), Seren Pharmaceuticals Pvt. Ltd (China), Pfizer Inc. (US), Valeant Pharmaceuticals (Canada), Janssen Biotech (US), Galderma (Switzerland), Sciton Inc (US), Sanofi Ltd. (France), Bristol Meyer Squibb company (US), Cutera Inc. (US), Novartis AG (Switzerland), Topica Pharmaceuticals Inc. (US), Taro Pharmaceutical Industries Ltd. (US), Nuvo Research Inc. (Canada), Merz Pharma gmbh& co. kgaa (Germany), Viamet Pharmaceuticals Inc. (US), NanoBio Corporation (US), NovaBiotics Ltd (UK), and others.

Comments

Post a Comment

Popular posts from this blog

Breathing Disorders And Treatments Market is Increasing at an Phenomenal CAGR During Forecast to 2023

  Market Overview: Breathing disorders are caused due to multiple factors that affect the respiratory system such as diseases such as allergies, infections and diseases like asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and others. Market Research Future (MRFR) has published a study report stating that the global breathing disorders and treatment market is registered to expand at a moderate pace and is anticipated to project high growth potential over the coming years.     Get a Free Sample @ https://www.marketresearchfuture.com/reports/breathing-disorders-treatment-market-1575     Market Drivers and Restraints: Increasing air pollution is one of the major causes that are triggering breathing disorders and respiratory diseases in highly populated regions. rise in prevalence of breathing disorders caused due to anthropogenic activities and other factors are inducing high demand for effective treatments all over the worl...
Read more

Dental Forceps Market is Rising at a Healthy CAGR of 5.2% During Forecast to 2024

Market Highlights: Numerous factors, such as the growing demand for dental forceps for performing several types of dental surgical procedures and the increasing number of dental practitioners and dental clinics, are anticipated to propel the growth of the market. Additionally, the growing incidence of dental diseases and the growing demand for cosmetic dentistry is likely to boost the growth of the market during the forecast period. According to the data published by the National Health Services (NHS), about 22.1 million adults were seen by an NHS dentist in the period, July 2016-July 2018. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/8012 The global Dental Forceps Market is anticipated to register a CAGR of 5.2 % during the forecast period of 2019 to 2024, with an estimated market value of USD 451.58 million in 2018. However, the availability of advanced dental equipment and limited reimbursement for dental surgeries are som...
Read more

Dental Forceps Market is Analytically Rising at a Healthy ACGR of 5.2% During Forecast to 2024

  Market Highlights: The global Dental Forceps Market is anticipated to register a CAGR of 5.2 % during the forecast period of 2019 to 2024, with an estimated market value of USD 451.58 million in 2018. However, the availability of advanced dental equipment and limited reimbursement for dental surgeries are some factors that may hinder the market growth during the assessment period. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/8012 Numerous factors, such as the growing demand for dental forceps for performing several types of dental surgical procedures and the increasing number of dental practitioners and dental clinics, are anticipated to propel the growth of the market. Additionally, the growing incidence of dental diseases and the growing demand for cosmetic dentistry is likely to boost the growth of the market during the forecast period. According to the data published by the National Health Services (NHS), about 22....
Read more